Mar. 3, 2026
Insilico Medicine and Liquid AI Announce Strategic Partnership for Drug Discovery AI Models
Collaboration produces lightweight 2.6B-parameter foundation model that matches or outperforms larger systems across drug discovery benchmarks
Feb. 26, 2026
US Biotechs Debate Losing Ground to China
Investors, CEOs, and scientists discuss the rise of Chinese biotech and what it means for the US industry
Feb. 24, 2026
Draper and Partners Awarded ARPA-H Funding for In Silico Drug Development Models
The $26.7 million award will support the development of new computer models that mimic human biology to predict drug safety and effectiveness.
Feb. 21, 2026
Draper Develops Sustained Immune Cell Recirculation in Microphysiological System
New platform enables long-term study of immune response in disease modeling
Feb. 18, 2026
AI Model May Slash Protein Drug Development Costs
MIT engineers use large language model to optimize protein production in industrial yeast, potentially reducing costs of new biologic drugs.
Feb. 14, 2026
Batista Lab Unveils Antibody Role in B Cell Diversity
Study finds antibodies themselves act as a "brake" to limit further selection against a particular target, redirecting immune response.
Feb. 14, 2026
Antibody feedback reshapes B cell selection during immune response
Researchers uncover a new mechanism governing how the immune system selects the most effective B cells, with implications for vaccine design.
Feb. 11, 2026
MIT Leaders Urge Defending Scientific Method Amid AI Advances
Noubar Afeyan and Sally Kornbluth discuss the role of science, technology, and higher education in a changing world.
Feb. 11, 2026
Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program for AI-Driven Cell Therapy Manufacturing
Partnership accelerates development of autonomous workflows in GMP cleanroom environments
Feb. 11, 2026
MIT Researchers Use Synthetic Biology and AI to Combat Antimicrobial Resistance
Three-year, $3 million project aims to develop new targeted antibacterials to address growing global threat
Feb. 9, 2026
DNA Twisting, Not Knots, Explained in Nanopore Research
Cambridge study reveals plectonemes, not knots, cause complex electrical signals in DNA analysis.
Feb. 9, 2026
Gene editing pioneer David Liu unlocks new treatments for rare diseases
Liu's inventions like 'base editing' and 'prime editing' are transforming the field of genetic medicine.
Feb. 6, 2026
Scientists Identify Language Network in Brain's Cerebellum
MIT researchers find dedicated language-processing regions in the cerebellum, extending the brain's language network.
Feb. 6, 2026
New Vaccine Platform Promotes Rare Protective B Cells
MIT and Scripps researchers develop a DNA-based vaccine that generates more of the desired B cells for HIV antibodies than a protein-based vaccine.
Feb. 4, 2026
Insilico Medicine Receives $5 Million Milestone Payment from Menarini Group
Payment follows first-in-human dosing of MEN2501, an AI-discovered cancer drug candidate
